• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性磷酸二酯酶 5 型抑制对 2 型糖尿病小鼠皮下脂肪组织的可塑性具有有益作用。

Chronic phosphodiesterase type 5 inhibition has beneficial effects on subcutaneous adipose tissue plasticity in type 2 diabetic mice.

机构信息

Department of Experimental Medicine, Sapienza University, Rome, Italy.

Department of Anatomical, Histological, Forensic, and Orthopaedic Sciences, Sapienza University, Rome, Italy.

出版信息

J Cell Physiol. 2018 Nov;233(11):8411-8417. doi: 10.1002/jcp.26796. Epub 2018 May 24.

DOI:10.1002/jcp.26796
PMID:29797572
Abstract

Different adipose tissue (AT) depots are associated with multiple metabolic risks. Phosphodiesterase type 5 (PDE5) is involved in adipocyte physiology and PDE5 inhibition may affect adipogenesis and ameliorate white AT quality. The aim of this study is to investigate the distribution of AT and the composition of the stroma-vascular fraction (SVF) of subcutaneous AT (SAT) in type 2 diabetic mice after prolonged treatment with a PDE5 inhibitor, Sildenafil. 18 db/db mice were treated with Sildenafil or vehicle for 12 weeks. AT distribution was monitored and SAT was processed for isolation of SVF by flow cytometry. Sildenafil induced an overall reduction in AT, mainly in visceral AT (VAT), compared with SAT. In Sildenafil-treated mice, the mean change in body weight from baseline positively correlated with VAT, but not with SAT. Characterization of SVF of SAT showed an increase in the frequency of M2 macrophages and endothelial cells in treated mice. Sildenafil improved the maintenance of SAT homeostasis and distribution.

摘要

不同的脂肪组织(AT)与多种代谢风险相关。磷酸二酯酶 5(PDE5)参与脂肪细胞的生理过程,PDE5 抑制可能影响脂肪生成并改善白色 AT 的质量。本研究旨在探讨在长期使用 PDE5 抑制剂西地那非治疗 2 型糖尿病小鼠后,其皮下脂肪组织(SAT)的 AT 分布和基质血管部分(SVF)的组成。18 只 db/db 小鼠接受西地那非或载体治疗 12 周。监测 AT 分布,并通过流式细胞术分离 SAT 的 SVF。与 SAT 相比,西地那非治疗导致整体脂肪量减少,主要是内脏脂肪(VAT)减少。在西地那非治疗的小鼠中,从基线开始的体重平均变化与 VAT 呈正相关,但与 SAT 无关。SAT 的 SVF 特征表明,治疗小鼠中 M2 巨噬细胞和内皮细胞的频率增加。西地那非改善了 SAT 体内平衡和分布的维持。

相似文献

1
Chronic phosphodiesterase type 5 inhibition has beneficial effects on subcutaneous adipose tissue plasticity in type 2 diabetic mice.慢性磷酸二酯酶 5 型抑制对 2 型糖尿病小鼠皮下脂肪组织的可塑性具有有益作用。
J Cell Physiol. 2018 Nov;233(11):8411-8417. doi: 10.1002/jcp.26796. Epub 2018 May 24.
2
Telomere length differences between subcutaneous and visceral adipose tissue in humans.人类皮下脂肪组织与内脏脂肪组织之间的端粒长度差异。
Biochem Biophys Res Commun. 2015 Feb 13;457(3):426-32. doi: 10.1016/j.bbrc.2014.12.122. Epub 2015 Jan 13.
3
PDE5 Inhibition Ameliorates Visceral Adiposity Targeting the miR-22/SIRT1 Pathway: Evidence From the CECSID Trial.PDE5 抑制通过 miR-22/SIRT1 通路改善内脏脂肪:CECSID 试验的证据。
J Clin Endocrinol Metab. 2016 Apr;101(4):1525-34. doi: 10.1210/jc.2015-4252. Epub 2016 Mar 10.
4
Induction of adipocyte hyperplasia in subcutaneous fat depot alleviated type 2 diabetes symptoms in obese mice.皮下脂肪库中脂肪细胞增生的诱导减轻了肥胖小鼠的2型糖尿病症状。
Obesity (Silver Spring). 2014 Jul;22(7):1623-31. doi: 10.1002/oby.20705. Epub 2014 Feb 11.
5
Crocus sativus tepals extract suppresses subcutaneous adipose tissue hypertrophy and improves systemic insulin sensitivity in mice on high-fat diet.番红花花瓣提取物可抑制高脂肪饮食诱导的小鼠皮下脂肪组织肥大,并改善其全身胰岛素敏感性。
Biofactors. 2024 Jul-Aug;50(4):828-844. doi: 10.1002/biof.2043. Epub 2024 Feb 6.
6
Two Faces of White Adipose Tissue with Heterogeneous Adipogenic Progenitors.白色脂肪组织两面观:具有异质性脂肪生成祖细胞。
Diabetes Metab J. 2019 Dec;43(6):752-762. doi: 10.4093/dmj.2019.0174.
7
Adipose depot-specific effects of 16 weeks of pioglitazone on in vivo adipogenesis in women with obesity: a randomised controlled trial.16 周吡格列酮治疗肥胖女性体内脂肪生成的脂肪组织特异性作用:一项随机对照试验。
Diabetologia. 2021 Jan;64(1):159-167. doi: 10.1007/s00125-020-05281-7. Epub 2020 Oct 1.
8
Sildenafil induces browning of subcutaneous white adipose tissue in overweight adults.西地那非可诱导超重成年人皮下白色脂肪组织的褐色化。
Metabolism. 2018 Jan;78:106-117. doi: 10.1016/j.metabol.2017.09.008. Epub 2017 Oct 3.
9
A Role of the Inflammasome in the Low Storage Capacity of the Abdominal Subcutaneous Adipose Tissue in Obese Adolescents.炎性小体在肥胖青少年腹部皮下脂肪组织低储存能力中的作用
Diabetes. 2016 Mar;65(3):610-8. doi: 10.2337/db15-1478. Epub 2015 Dec 30.
10
Obesity enhances the recruitment of mesenchymal stem cells to visceral adipose tissue.肥胖会增强间充质干细胞向内脏脂肪组织的募集。
J Mol Endocrinol. 2021 Jun 17;67(1):15-26. doi: 10.1530/JME-20-0229.

引用本文的文献

1
Pharmacological Support for the Treatment of Obesity-Present and Future.肥胖治疗的药物支持——现状与未来
Healthcare (Basel). 2023 Feb 2;11(3):433. doi: 10.3390/healthcare11030433.
2
cAMP-specific phosphodiesterase 8A and 8B isoforms are differentially expressed in human testis and Leydig cell tumor.cAMP 特异性磷酸二酯酶 8A 和 8B 同工型在人睾丸和莱迪希细胞瘤中差异表达。
Front Endocrinol (Lausanne). 2022 Oct 7;13:1010924. doi: 10.3389/fendo.2022.1010924. eCollection 2022.
3
A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease.
基于人类的多基因标志物可实现代谢疾病的药物重新定位定量分析。
Elife. 2022 Jan 17;11:e68832. doi: 10.7554/eLife.68832.
4
Targeting the NO-cGMP-PDE5 pathway in COVID-19 infection. The DEDALO project.针对 COVID-19 感染的 NO-cGMP-PDE5 通路。DEDALO 项目。
Andrology. 2021 Jan;9(1):33-38. doi: 10.1111/andr.12837. Epub 2020 Jul 3.